Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use

KL Wijnsma, C Duineveld, JFM Wetzels… - Pediatric …, 2019 - Springer
With the introduction of the complement C5-inhibitor eculizumab, a new era was entered for
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …

Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation

S Obata, F Hullekes, LV Riella, P Cravedi - Transplantation Reviews, 2024 - Elsevier
Hereditary forms of hemolytic uremic syndrome (HUS), formerly known as atypical HUS,
typically involve mutations in genes encoding for components of the alternative pathway of …

Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice

LGM De Andrade, MM Contti, HS Nga, AM Bravin… - PLoS …, 2017 - journals.plos.org
Introduction The treatment of choice for Atypical Hemolytic Uremic Syndrome (aHUS) is the
monoclonal antibody eculizumab. The objective of this study was to assess the efficacy and …

Midterm outcomes of 12 renal transplant recipients treated with eculizumab to prevent atypical hemolytic syndrome recurrence

C Levi, V Frémeaux-Bacchi, J Zuber, M Rabant… - …, 2017 - journals.lww.com
Background Atypical hemolytic uremic syndrome (aHUS) is an orphan disease with a high
rate of recurrence after kidney transplantation. However, reports of successful prevention of …

[HTML][HTML] A case report and literature review of eculizumab withdrawal in atypical hemolytic-uremic syndrome

B Quiroga, A de Lorenzo, C Vega… - The American Journal of …, 2016 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Recent advances in the treatment of atypical
hemolytic-uremic syndrome (aHUS) have resulted to better long-term survival rates for …

Pediatric Renal Transplantation

A Chen, JJ Lin, AM South - Kidney Transplantation, Bioengineering and …, 2017 - Elsevier
Kidney transplantation is the treatment of choice for pediatric patients with end-stage renal
disease. With the advance in immunosuppression, surgical techniques, and posttransplant …

[引用][C] Complement inhibition is efficient in early but not late antibody-mediated rejection after kidney transplantation

M Elias, E Nnang-Obada, S Beaudreuil, C Suberbielle… - International Journal of …, 2018